Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non–small-cell Lung CancerBuhai Wang, Ye Gao,Yuxiang Huang,Qiuxiang Ou, Tingting Fang, Chunhui Tang,Xue Wu,Yang W. ShaoClinical Lung Cancer(2018)引用 13|浏览7关键词Crizotinib,IRF2BP2,NSCLC,NTRK fusion,Pan-TRK inhibitorAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要